Belviq Study Results May Improve The Fortunes Of Weight-Loss Drugs

In the past decade, the armamentarium of pharmacologic therapies has expanded to include drugs such as the weight-loss drugs Contrave (bupropion/naltrexone), Qysmia (phentermine/topiramate), and Belviq (lorcaserin). Until now, however, weight-loss drugs https://www.forbes.com/sites/joshuacohen/2018/09/10/belviq-study-results-may-improve-the-fortunes-of-weight-loss-drugs/#48544a5e6a40